↓ Direkt till sidans innehåll
↓ Direkt till sidans sekundära innehåll (sidomenyn)

Tyck till om SwePub Sök här!

Träfflista för sökning "WFRF:(Quinti I) srt2:(2015-2019)"

Search: WFRF:(Quinti I) > (2015-2019)

Result 1-3 of 3

Sort/group result

Sort by: Hits per page:

Enumeration	Reference	Cover	Find
1.	Bonilla, FA, et al. (author) International Consensus Document (ICON): Common Variable Immunodeficiency Disorders 2016 In: The journal of allergy and clinical immunology. In practice. - : Elsevier BV. - 2213-2201 .- 2213-2198. ; 4:1, s. 38-59 Journal article (peer-reviewed)
2.	Na, I. K., et al. (author) Current clinical practice and challenges in the management of secondary immunodeficiency in hematological malignancies 2019 In: European Journal of Haematology. - : Wiley. - 0902-4441 .- 1600-0609. ; 102:6, s. 447-456 Journal article (peer-reviewed)abstract Objective Despite long-standing safe and effective use of immunoglobulin replacement therapy (IgRT) in primary immunodeficiency, clinical data on IgRT in patients with secondary immunodeficiency (SID) due to B-cell lymphoproliferative diseases are limited. Here, we examine the correlation between approved IgRT indications, treatment recommendations, and clinical practice in SID. Methods An international online survey of 230 physicians responsible for the diagnosis of SID and the prescription of IgRT in patients with hematological malignancies was conducted. Results Serum immunoglobulin was measured in 83% of patients with multiple myeloma, 76% with chronic lymphocytic leukemia, and 69% with non-Hodgkin lymphoma. Most physicians (85%) prescribed IgRT after >= 2 severe infections. In Italy, Germany, Spain, and the United States, immunoglobulin use was above average in patients with hypogammaglobulinemia, while in the UK considerably fewer patients received IgRT. The use of subcutaneous immunoglobulin was highest in France (34%) and lowest in Spain (19%). Immunologists measured specific antibody responses, performed test immunization, implemented IgRT, and used subcutaneous immunoglobulin more frequently than physicians overall. Conclusions The management of SID in hematological malignancies varied regionally. Clinical practice did not reflect treatment guidelines, highlighting the need for robust clinical studies on IgRT in this population and harmonization between countries and disciplines.
3.	Bomken, S, et al. (author) Current Understanding and Future Research Priorities in Malignancy Associated With Inborn Errors of Immunity and DNA Repair Disorders: The Perspective of an Interdisciplinary Working Group 2018 In: Frontiers in immunology. - : Frontiers Media SA. - 1664-3224. ; 9, s. 2912- Journal article (peer-reviewed)

Skapa referenser, mejla, bekava och länka

Permalink

Result 1-3 of 3

Refine your search

Type of publication: journal article (3)

Type of content: peer-reviewed (3)

Author/Editor: Quinti, I (3); Warnatz, K (2); Hammarstrom, L (1); Fischer, U (1); Sanchez-Ramon, S (1); Pan-Hammarstrom, Q (1); show more...; Cunningham-Rundles, ... (1); Buckland, M (1); Agostini, C (1); Chapel, H (1); Nonoyama, S (1); Tang, MLK (1); Attarbaschi, A (1); Bacon, CM (1); Neven, B (1); Lankester, AC (1); Boztug, K (1); Seidel, MG (1); Michallet, M (1); Bomken, S. (1); Loeffen, J. (1); Gennery, AR (1); Friman, Vanda, 1952 (1); Borkhardt, A. (1); Costa-Carvalho, BT (1); Ten Bosch, JV (1); Hauck, F (1); Kuiper, RP (1); Lammens, T (1); Wehr, C (1); Bonilla, FA (1); Barlan, I (1); de la Morena, MT (1); Espinosa-Rosales, FJ (1); Routes, JM (1); Scheibenbogen, C (1); Na, I. K. (1); Edgar, J. D. M. (1); show less...

University: Karolinska Institutet (2); University of Gothenburg (1)

Language: English (3)

Research subject (UKÄ/SCB): Medical and Health Sciences (1)

Year

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

Copyright © LIBRIS - National Library Systems
LIBRIS.kb.se

pil uppåt

Close

Copy and save the link in order to return to this view